Dr Abdul Mannan: Iron Deficiency Can Hide Beta-Thalassaemia Trait
Dr Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board shared a post on LinkedIn:
”Iron deficiency can hide beta-thalassaemia trait.
This creates a real problem in antenatal screening.
Here’s why: Low iron falsely lowers HbA₂ levels. The result? A pregnant woman with beta-thalassaemia trait can get a false-negative result. And that means missed genetic counselling.
The solution is simple. Don’t wait.
Here’s what every obstetric team needs to know:
Screen at booking, even if iron deficiency is suspected. Don’t delay haemoglobin variant analysis.
Borderline HbA₂ (3.0-3.4%) with low ferritin (<30 µg/L)? Start iron therapy and retest after 8-12 weeks.
Test the partner in parallel if the maternal result is positive or borderline. Time matters.
When results remain unclear, escalate to DNA testing. Don’t guess.
The UK NHS Sickle Cell and Thalassaemia Screening Programme is clear on this: Timing keeps options open for couples who may be at risk of having a child with thalassaemia major.
Are you seeing borderline HbA₂ results in your antenatal patients? How do you handle them?”
More posts from Dr Abdul Mannan on Hemostasis Today.
-
Jan 17, 2026, 05:01Fortis Memorial Research Institute, Gurugram Ranked Among the World’s Top 50 Smart Hospitals
-
Jan 17, 2026, 04:59Flora Peyvandi: Factor VIII in Vitro Bioequivalence of Mim8 Haemostatic Effect
-
Jan 17, 2026, 04:58Desmopressin in Bleeding Disorders: 5,000 Views in 6 Months – Why This Topic Matters
-
Jan 17, 2026, 04:58Sifat Jubaira Shares Chylous Blood Clinical Case: Milky Blood Instead of Red
-
Jan 17, 2026, 04:57Automated VWF Multimer Analysis Using Deep Learning for Improved Diagnosis and Classification of vWD
-
Jan 17, 2026, 04:55Trends in Catheter-Directed Therapy and In-Hospital Outcomes in Acute PE
-
Jan 17, 2026, 04:54Antithrombin III Deficiency – Explained by Astha Thakkar
-
Jan 17, 2026, 04:53Antiphospholipid Syndrome: Not All Antibodies Are Created Equal
-
Jan 17, 2026, 04:53FDA Approval of Mitapivat: Redefining Thalassemia Management